Cross-method comparison for BRAF p.V600 mutation cfDNA testing in Melanoma: BRAFI study by Clara Mayo de las Casas, Eloisa Jantus-Lewintre, Sebastian Ortiz Reina, Ana Drozdowskyj, Pablo Cerezuela-Fuentes, Jose Luis Manzano, Pablo Ayala de Miguel, Ana Arance Fernandez, Miguel Angel Berciano-Guerrero, Almudena Garcia-Castaño, Teresa Puertolas, Guillermo Crespo, Maria Quindos-Varela, Juan Francisco Rodriguez-Moreno, Alfonso Berrocal, Eva Muñoz-Couselo, Enrique Espinosa, Joselyn Valarezo, Susana Muñoz, Silvia Calabuig-Fariñas, Miguel Angel Molina, Rafael Rosell, Joan Anton Puig-Butille, Maria Gonzalez-Cao

Subjects: Get full text

High-grade astrocytoma with piloid features: a single-institution case series and literature review by Eric A. Goethe, Subhiksha Srinivasan, Swaminathan Kumar, Sujit S. Prabhu, Maria A. Gubbiotti, Sherise D. Ferguson

Subjects: Get full text

An 8-year-old girl with secondary histiocytic sarcoma with BRAFV600 mutation following T-cell acute lymphoblastic leukemia demonstrating stable disease for 3 years on dabrafenib an... by Sue Lyn Tan, Betty Lee Sue Ho, Ting Ting Yew, Dahziela Yunus

Subjects: Get full text

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis by Woon Won Kim, Tae Kwun Ha, Sung Kwon Bae

Subjects: “…BRAF mutation…”
Get full text

Case Report: A case of synchronous multiple early gastric cancer with a microsatellite instability-high phenotype by Xinshuo Wang, Yifan Zhang, Guangyan Fan, Honglei Wu, Xing Qi, Xiujie Cui, Chengjun Zhou

Subjects: Get full text

Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review by Nina Yu, Osama A Raslan, Han Sung Lee, Brett J Theeler, Tarek A Raafat, Ruben Fragoso, Kiarash Shahlaie, Orwa Aboud

Subjects: Get full text

Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations by J. Ros, V. Navarro, G. Villacampa, I. Baraibar, F. Salvà, M. Rodriguez, C. Vaghi, A. Garcia, A. Alcaraz, J. Tabernero, E. Élez, R. Dienstmann

Subjects: Get full text

Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis by Michael G. White, Reed I. Ayabe, Mohammad A. Zeineddine, Fadl A. Zeineddine, Abdelrahman M.G. Yousef, Mahmoud Yousef, Norman J. Galbraith, J․Bryan Iorgulescu, Christopher Scally, Keith Fournier, Timothy E. Newhook, Nancy Y. You, Jason Willis, Scott Kopetz, George J. Chang, John Paul Shen, Abhineet Uppal

Subjects: Get full text

Metabolic parameters on baseline and early [18F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma by Bernies van der Hiel, Berlinda J. de Wit - van der Veen, Alfons J. M. van den Eertwegh, Wouter V. Vogel, Marcel P. M. Stokkel, Marta Lopez-Yurda, Ronald Boellaard, Ellen W. Kapiteijn, Geke A. P. Hospers, Maureen J. B. Aarts, Filip Y. F. L. de Vos, Marye J. Boers-Sonderen, Astrid A. M. van der Veldt, Jan Willem B. de Groot, John B. A. G. Haanen

Subjects: Get full text

A compilation of 13 patients with metastatic colorectal cancer and concomitant BRAF and RAS family mutations by Jigisha Srivastav, Morgan E. Lehman, Joni K. Evans, Ravi Paluri, Caio Max Sao Pedro Rocha Lima

Subjects: Get full text

Metastatic Low‐Grade Glioma Successfully Treated in a Pediatric Patient With BRAF A598_T599insI Mutation by Pierluigi Calò, Safiatou Diallo, Laetitia Lebrun, Nathalie Gilis, Marco Preziosi, Pierre Leblond

Subjects: Get full text

Comprehensive Survey of AACR GENIE Database of Tumor Mutation Burden (TMB) Among All Three Classes (I, II, III) of BRAF Mutated (BRAF+) NSCLC by Arter ZL, Shieh K, Nagasaka M, Ou SHI

Subjects: Get full text

PREDICTORS OF AGGRESSIVE DIFFERENTIATED THYROID CANCER. A REPORT OF A CASE OF PAPILLARY THYROID CANCER by R. A. Murashko, A. S. Shatokhina, A. I. Stukan, D. V. Andreev, E. V. Dulina

Subjects: Get full text

Systemic therapy of skin metastatic melanoma with BRAF gene mutation by Yu. S. Shakh-Paronyants, S. V. Cheporov, N. P. Shiryaev, A. V. Ukgarskiy, P. V. Nesterov, N. S. Korzina

Subjects: Get full text

Braf-Mutant Melanomas: Biology and Therapy by Elvira Pelosi, Germana Castelli, Ugo Testa

Subjects: Get full text

Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers by S. Pradervand, N. Freundler, B. Gosztonyi, L. Roncoroni, R. Achermann, T. Schwenk, G. de Fraipont, J. Garessus, S. Haefliger, A.B. Leichtle, M.K. Kiessling, T. Mueller-Focke, F.S. Krebs, V. Zoete, P. Tsantoulis, O. Michielin, C. Britschgi, A. Wicki

Subjects: “…BRAF mutations…”
Get full text

Molecular heterogeneity and analysis of the long-term survival of patients with gastrointestinal stromal tumors by N. N. Mazurenko, V. V. Yugay, I. V. Tsyganova, M. P. Nikulin, P. P. Arkhiri, O. A. Anurova, N. A. Kozlov, I. S. Stilidi

Subjects: Get full text

Impact of RAS, BRAF mutations and microsatellite status in peritoneal metastases from colorectal cancer treated with cytoreduction + HIPEC: scoping review by Valentina Zucchini, Fabrizio D’Acapito, Ilario Giovanni Rapposelli, Massimo Framarini, Daniela Di Pietrantonio, Riccardo Turrini, Eleonora Pozzi, Giorgio Ercolani

Subjects: Get full text

Association of gut microbiota and immune gene expression with response to targeted therapy in BRAF mutated melanoma by Mora Guardamagna, Miguel-Angel Berciano-Guerrero, Rocío Lavado-Valenzuela, Édouard Auclin, Juan Luis Onieva-Zafra, Isaac Plaza-Andrades, Javier Oliver, Alicia Garrido-Aranda, Elisabeth Perez-Ruiz, Martina Álvarez, María Carmen Ocaña, María Isabel Queipo-Ortuño, Isabel Barragán, Antonio Rueda-Dominguez

Subjects: Get full text

CLINICAL AND ECONOMIC EVALUATION OF ATEZOLIZUMAB + VEMURAFENIB + COBIMETINIB COMBINATION AND NIVOLUMAB + IPILIMUMAB COMBINATION: ADMINISTRATION IN METASTATIC MELANOMA TREATMENT WIT... by I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova

Subjects: Get full text